STUART A ISSLEIB

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology LA GRANGE HIGHLANDS, IL NPI 1497740393

General Payments — all program years on this page

$2,079.49

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 90
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $338.20 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $338.2016

By paying entity

Latest program year (PY2023) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $119.998
2019 $171.1010
2020 $538.0820
2021 $733.9923
2022 $178.1313
2023 $338.2016

Records — PY2023 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1014741603 Celgene Corporation $15.03 03/30/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1014741649 Celgene Corporation $16.70 07/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1022028815 Boston Scientific Corporation $15.11 10/12/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048515709 Merck Sharp & Dohme LLC $15.08 06/08/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1048515711 Merck Sharp & Dohme LLC $15.64 02/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057121513 Salix Pharmaceuticals, a division of Bausch Health US, LLC $6.99 07/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057160211 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.56 09/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057264395 Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.82 02/01/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057264933 Salix Pharmaceuticals, a division of Bausch Health US, LLC $5.97 09/28/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057319349 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.92 05/22/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057344499 Salix Pharmaceuticals, a division of Bausch Health US, LLC $6.94 02/27/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057362629 Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.50 11/09/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057397665 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.87 10/18/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057431113 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.05 03/14/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1057499403 Salix Pharmaceuticals, a division of Bausch Health US, LLC $131.79 05/31/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
997539439 ABBVIE INC. $14.23 04/06/2023 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.